Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HQY
HQY logo

HQY Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
87.890
Open
86.280
VWAP
86.14
Vol
434.19K
Mkt Cap
7.29B
Low
85.000
Amount
37.40M
EV/EBITDA(TTM)
16.44
Total Shares
84.48M
EV
7.93B
EV/OCF(TTM)
17.35
P/S(TTM)
5.75
HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.
Show More

Events Timeline

(ET)
2026-04-06
17:10:00
HealthEquity Terminates CTO Eli Rosner's Employment
select
2026-03-17 (ET)
2026-03-17
16:10:00
Company Sees FY27 Revenue of $1.41B to $1.42B
select
2026-03-17
16:10:00
HealthEquity Q4 Revenue $334.6M, Adjusted EBITDA Up 23%
select
2026-03-17
14:10:00
Lululemon and Others Set to Report Earnings, Consensus at $4.78
select

News

seekingalpha
6.0
04-09seekingalpha
BMO Upgrades HealthEquity to Outperform Amid Growth Optimism
  • Rating Upgrade: BMO Capital Markets upgraded HealthEquity's rating from Market Perform to Outperform, with analyst Sean Dodge highlighting that fears related to AI are overblown, suggesting the current stock price offers a compelling entry point for investors.
  • Increased Growth Expectations: Dodge raised HealthEquity's long-term growth estimates from mid-single digits/high single digits to high single digits/low double digits, indicating that the recent launch of the Marketplace business will create additional monetization opportunities for its member base, further driving revenue growth.
  • Price Target Increase: BMO raised HealthEquity's price target from $85 to $105 per share, reflecting confidence in the company's future performance and anticipating benefits from the successful implementation of its Marketplace business.
  • Strong Financial Performance: HealthEquity's recent non-GAAP EPS of $0.95 exceeded expectations by $0.05, while revenue of $334.6 million surpassed estimates by $1.78 million, indicating ongoing improvements in the company's financial health.
seekingalpha
9.5
04-07seekingalpha
Medicare Advantage Payments Increase by 2.48%, Boosting Insurer Stocks
  • Payment Increase Impact: The Centers for Medicare & Medicaid Services announced a 2.48% increase in Medicare Advantage payments for 2027, leading to significant stock price surges among major healthcare insurers in after-hours trading on Monday, reflecting market optimism regarding insurers' profitability.
  • Significant Market Reaction: Following this announcement, Centene Corporation (CNC) saw a 4.3% increase, UnitedHealth Group (UNH) rose by 7.8%, and Humana (HUM) surged by 11%, indicating heightened investor confidence in the healthcare insurance sector's outlook.
  • Quantitative Rating Insights: According to Quant ratings, HealthEquity (HQY) leads with a score of 3.57, followed by Centene (3.38) and Alignment Healthcare (3.30), providing investors with valuable insights for selecting insurance providers based on performance metrics.
  • Future Outlook: This payment increase is expected to generate an additional $18 billion in revenue for insurers, further driving industry growth while potentially influencing future premium rates and benefit structures, thereby enhancing the competitive positioning of insurance companies.
Newsfilter
5.0
03-30Newsfilter
HealthEquity Appoints New Board Member to Enhance Governance
  • Board Expansion: HealthEquity announced the election of William Gassen, CEO of Sanford Health, to its board effective March 26, 2026, increasing the board to 10 members, 8 of whom are independent, thereby enhancing corporate governance.
  • Rich Industry Experience: Gassen's leadership experience at Sanford Health will provide HealthEquity with deep insights into healthcare delivery and financing, helping the company better address the challenges faced by consumers, providers, and employers in the healthcare system.
  • Focus on Affordability: Gassen emphasized that affordability in healthcare remains a significant challenge for many families and employers, and HealthEquity plays a crucial role in helping people prepare for healthcare expenses, further solidifying the company's market position.
  • Educational Background and Professional Experience: Gassen holds a bachelor's degree in criminal justice and a J.D. from the University of South Dakota, and has held several senior leadership roles at Sanford Health, bringing a diverse perspective to the board.
moomoo
5.0
03-30moomoo
HEALTHEQUITY NAMES BILL GASSEN, CEO OF SANFORD HEALTH, TO ITS BOARD OF DIRECTORS
  • Health Equity Appointment: Bill Gassen has been appointed as the CEO of Sanford Health, focusing on health equity initiatives.

  • Board of Directors: Gassen will also serve on the Board of Directors, contributing to strategic decisions and governance.

Yahoo Finance
9.5
03-18Yahoo Finance
HealthEquity Reports Significant Q4 Growth
  • Revenue and Net Income Growth: HealthEquity reported a 7% year-over-year revenue increase to $334.6 million in Q4, with net income soaring 89% to $49.7 million, indicating strong market performance and enhanced profitability.
  • HSA Account Expansion: The company added a record 550,000 Health Savings Accounts (HSAs) in Q4, bringing the total to 17.8 million accounts, reflecting robust growth potential and an expanding customer base in the health savings market.
  • Shareholder Returns and Cash Flow: HealthEquity returned over $300 million to shareholders through its share repurchase program, reducing diluted shares by approximately 3%, while generating $457 million in cash flow from operations, enhancing financial flexibility.
  • Future Outlook and Guidance: The company expects fiscal 2027 revenue to be between $1.405 billion and $1.415 billion, with GAAP net income projected between $239 million and $246 million, demonstrating confidence in future growth and market opportunities.
NASDAQ.COM
2.0
03-18NASDAQ.COM
HealthEquity (HQY) Q4 2026 Earnings Transcript
Wall Street analysts forecast HQY stock price to rise
11 Analyst Rating
Wall Street analysts forecast HQY stock price to rise
9 Buy
1 Hold
1 Sell
Moderate Buy
Current: 0.000
sliders
Low
89.00
Averages
117.09
High
129.00
Current: 0.000
sliders
Low
89.00
Averages
117.09
High
129.00
BMO Capital
Sean Dodge
Market Perform
to
Outperform
upgrade
$85 -> $105
AI Analysis
2026-04-09
Reason
BMO Capital
Sean Dodge
Price Target
$85 -> $105
AI Analysis
2026-04-09
upgrade
Market Perform
to
Outperform
Reason
BMO Capital analyst Sean Dodge upgraded HealthEquity to Outperform from Market Perform with a price target of $105, up from $85. The firm says recent developments increase its conviction in HealthEquity's longer-range growth outlook. AI fears around the company are overblown and provide investors with an attractive entry point, the analyst tells investors in a research note. BMO believes HealthEquity's recent Marketplace launch establish a new, large, and high-margin growth opportunity.
Deutsche Bank
Buy
maintain
$120 -> $128
2026-03-19
Reason
Deutsche Bank
Price Target
$120 -> $128
2026-03-19
maintain
Buy
Reason
Deutsche Bank raised the firm's price target on HealthEquity to $128 from $120 and keeps a Buy rating on the shares. The firm says the company's visibility and execution continued in Q4.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HQY
Unlock Now

Valuation Metrics

The current forward P/E ratio for Healthequity Inc (HQY.O) is 18.62, compared to its 5-year average forward P/E of 32.97. For a more detailed relative valuation and DCF analysis to assess Healthequity Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
32.97
Current PE
18.62
Overvalued PE
44.54
Undervalued PE
21.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
18.35
Current EV/EBITDA
16.56
Overvalued EV/EBITDA
21.98
Undervalued EV/EBITDA
14.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
5.96
Current PS
4.81
Overvalued PS
6.89
Undervalued PS
5.03

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

stocks likely to go up 2% tomorrow morning
Intellectia · 12 candidates
Market Cap: >= 2.00BMoving Average Relationship: PriceAboveMA20One Day Rise Prob: >= 70One Day Predict Return: >= 2.0%Monthly Average Dollar Volume: >= 500,000
Ticker
Name
Market Cap$
top bottom
HCC logo
HCC
Warrior Met Coal Inc
4.24B
GD logo
GD
General Dynamics Corp
96.15B
FUTU logo
FUTU
Futu Holdings Ltd
21.38B
HQY logo
HQY
Healthequity Inc
6.71B
FIVE logo
FIVE
Five Below Inc
12.19B
ETOR logo
ETOR
eToro Group Ltd
2.50B
What stock has the most upside this 2026?
Intellectia · 48 candidates
Market Cap: 1000.00M - 100.00BAnalyst Consensus: Strong Buy, Moderate BuyRevenue 5yr Cagr: >= 10Eps 5yr Cagr: >= 10List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
KSPI logo
KSPI
Kaspi.kz AO
15.02B
QFIN logo
QFIN
Qfin Holdings Inc
2.14B
NICE logo
NICE
Nice Ltd
7.07B
PTC logo
PTC
PTC Inc
19.28B
JD logo
JD
JD.com Inc
42.34B
TW logo
TW
Tradeweb Markets Inc
24.31B
rerun right now to see if the list changes
Intellectia · 29 candidates
Price: $3.00 - $100.00Relative Vol: >= 1.50List Exchange: XNYS, XNAS, XASEOne Day Rise Prob: >= 60One Day Predict Return: >= 5.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
SIDU logo
SIDU
Sidus Space Inc
234.80M
DBGI logo
DBGI
Digital Brands Group Inc (Pre-Reincorporation)
68.45M
MED logo
MED
Medifast Inc
128.60M
AAP logo
AAP
Advance Auto Parts Inc
2.75B
CMBT logo
CMBT
CMB.TECH NV
3.30B
LSTA logo
LSTA
Lisata Therapeutics Inc
35.81M
show me more stocks like alit
Intellectia · 17 candidates
Market Cap: 3.00B - 12.00BRevenue Ttm: 1000.00M - 4.00BRegion: USWeekly Average Turnover: >= 3,000,000Annual Revenue Yoy Growth: 10.0% - 30.0%
Ticker
Name
Market Cap$
top bottom
BSY logo
BSY
Bentley Systems Inc
11.98B
NTNX logo
NTNX
Nutanix Inc
11.24B
CFLT logo
CFLT
Confluent Inc
10.82B
CART logo
CART
Maplebear Inc
10.24B
MANH logo
MANH
Manhattan Associates Inc
10.01B
PCOR logo
PCOR
Procore Technologies Inc
9.79B

Whales Holding HQY

W
Westfield Capital Management Company, L.P.
Holding
HQY
+11.61%
3M Return
A
Atalan Capital Partners, LP
Holding
HQY
+11.43%
3M Return
W
Wasatch Advisors LP
Holding
HQY
+7.83%
3M Return
A
Aristotle Capital Boston, LLC
Holding
HQY
+4.90%
3M Return
N
Nationwide Fund Advisors
Holding
HQY
+4.81%
3M Return
S
Stephens Investment Management Group, LLC
Holding
HQY
+3.71%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Healthequity Inc (HQY) stock price today?

The current price of HQY is 85.54 USD — it has decreased -0.92

What is Healthequity Inc (HQY)'s business?

HealthEquity, Inc. is engaged in providing technology-enabled services that enables consumers to make healthcare saving and spending decisions. The Company uses its technology to manage consumer tax-advantaged health savings accounts (HSAs) and other consumer-directed benefits (CDBs) offered by employers, including flexible spending accounts and health reimbursement arrangements (FSAs and HRAs), and to administer Consolidated Omnibus Budget Reconciliation Act (COBRA), commuter and other benefits. It provides consumers with payment processing services, personalized benefit information, the ability to earn wellness incentives, and investment advice. It offers an investment platform and access to an online-only automated investment advisory service to all of its members whose account balances exceed a stated threshold. It administers pre-tax commuter benefit programs through which employers are permitted to provide employees with commuter benefits including qualified transit and parking.

What is the price predicton of HQY Stock?

Wall Street analysts forecast HQY stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HQY is117.09 USD with a low forecast of 89.00 USD and a high forecast of 129.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Healthequity Inc (HQY)'s revenue for the last quarter?

Healthequity Inc revenue for the last quarter amounts to 334.59M USD, increased 7.30

What is Healthequity Inc (HQY)'s earnings per share (EPS) for the last quarter?

Healthequity Inc. EPS for the last quarter amounts to 0.58 USD, increased 93.33

How many employees does Healthequity Inc (HQY). have?

Healthequity Inc (HQY) has 2814 emplpoyees as of April 21 2026.

What is Healthequity Inc (HQY) market cap?

Today HQY has the market capitalization of 7.29B USD.